Glucagon antagonists
US6762318B2 · kind B2 · utility
37Cited by
13References
59Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2002 |
| Grant date | Jul 13, 2004 |
| Priority date | — |
| Expiry date | Dec 3, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4439
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.